Nutricosmetics Pose Intriguing Possibilities For Brands That Hit Wall With Skin-Care Claims
This article was originally published in The Rose Sheet
Statements about collagen production, maintaining cellular integrity, addressing age spots, even shrinking wrinkles and treating noncystic acne – all are viable structure/function claims for nutricosmetics, assuming there's evidence to back them up. The Rose Sheet discusses the growing opportunity with regulatory and legal experts and provides an overview of the market at present.
You may also be interested in...
If you're in the nutricosmetics game, the EU is the place to be, market researchers suggest. However, European regulations for health claims on food products put nutricosmetic brands in a tight spot.
The Capillus82 Hair Regrowth Laser Cap may be "substantially equivalent" to the manufacturer's Capillus272 Pro device, based on FDA's 510(k) clearance, but NAD says hair-growth clinical findings from that "predicate" device cannot serve to substantiate claims for the untested Capillus82. The case illustrates complexities in the medical device segment, which increasingly is of interest to cosmetics companies.
The "Moisturol" pill that Dateline NBC pitched in 2006 to test the integrity of the infomercial industry – because it "could not possibly work as advertised" – is a lot less outrageous today amid a global nutricosmetics boom. The Rose Sheet considers how the faux beauty-from-within innovation might fare with consumers and regulators in 2017.